Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Decker

Showing results (101-110 of 180) with videos related to

Pageof 18
Sort By:
Journal of Medicinal Chemistry|June 21, 2021
Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse ModelMatthias Scheiner, Matthias Hoffmann, Feng He, et al.
Journal of Medicinal Chemistry|February 18, 2010
Hybrid molecules from xanomeline and tacrine: enhanced tacrine actions on cholinesterases and muscarinic M1 receptorsLei Fang, Sabine Jumpertz, Yihua Zhang, et al.
Scientific Reports|May 12, 2017
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of small molecule inhibitor JQ1Tim-Michael Decker, Michael Kluge, Stefan Krebs, et al.
ACS Chemical Neuroscience|March 18, 2014
Acetylcholinesterase inhibitors with photoswitchable inhibition of β-amyloid aggregationXinyu Chen, Sarah Wehle, Natascha Kuzmanovic, et al.
CNS Neuroscience & Therapeutics|June 18, 2024
The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's diseaseAllison Carles, Matthias Hoffmann, Matthias Scheiner, et al.
Journal of Medicinal Chemistry|February 18, 2016
Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition ModeEdgar Sawatzky, Sarah Wehle, Beata Kling, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2025
Deciphering the structural impact of norepinephrine analog radiopharmaceuticals on organic cation transporter affinitySaskia Mühlig, Xinyu Chen, Anna Tutov, et al.
Life (Basel, Switzerland)|February 25, 2022
Expiratory Peak Flow and Minute Ventilation Are Significantly Increased at High Altitude versus Simulated Altitude in NormobariaNikolaus C Netzer, Linda K Rausch, Matthias Frieß, et al.
Orthopedic Research and Reviews|August 25, 2021
The Impact of Free Radical Stabilization Techniques on in vivo Mechanical Changes in Highly Cross-Linked Polyethylene Acetabular LinersMichael Decker, Amber Price, Aria Khalili, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 11, 2024
"Photo-Adrenalines": Photoswitchable β<sub>2</sub> -Adrenergic Receptor Agonists as Molecular Probes for the Study of Spatiotemporal Adrenergic SignalingAlexandra Sink, Hubert Gerwe, Harald Hübner, et al.
Pageof 18

Showing results (101-110 of 180) with videos related to

Sort By:
Pageof 18
Journal of Medicinal Chemistry|June 21, 2021
Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse ModelMatthias Scheiner, Matthias Hoffmann, Feng He, et al.
Journal of Medicinal Chemistry|February 18, 2010
Hybrid molecules from xanomeline and tacrine: enhanced tacrine actions on cholinesterases and muscarinic M1 receptorsLei Fang, Sabine Jumpertz, Yihua Zhang, et al.
Scientific Reports|May 12, 2017
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of small molecule inhibitor JQ1Tim-Michael Decker, Michael Kluge, Stefan Krebs, et al.
ACS Chemical Neuroscience|March 18, 2014
Acetylcholinesterase inhibitors with photoswitchable inhibition of β-amyloid aggregationXinyu Chen, Sarah Wehle, Natascha Kuzmanovic, et al.
CNS Neuroscience & Therapeutics|June 18, 2024
The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's diseaseAllison Carles, Matthias Hoffmann, Matthias Scheiner, et al.
Journal of Medicinal Chemistry|February 18, 2016
Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition ModeEdgar Sawatzky, Sarah Wehle, Beata Kling, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2025
Deciphering the structural impact of norepinephrine analog radiopharmaceuticals on organic cation transporter affinitySaskia Mühlig, Xinyu Chen, Anna Tutov, et al.
Life (Basel, Switzerland)|February 25, 2022
Expiratory Peak Flow and Minute Ventilation Are Significantly Increased at High Altitude versus Simulated Altitude in NormobariaNikolaus C Netzer, Linda K Rausch, Matthias Frieß, et al.
Orthopedic Research and Reviews|August 25, 2021
The Impact of Free Radical Stabilization Techniques on in vivo Mechanical Changes in Highly Cross-Linked Polyethylene Acetabular LinersMichael Decker, Amber Price, Aria Khalili, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 11, 2024
"Photo-Adrenalines": Photoswitchable β<sub>2</sub> -Adrenergic Receptor Agonists as Molecular Probes for the Study of Spatiotemporal Adrenergic SignalingAlexandra Sink, Hubert Gerwe, Harald Hübner, et al.
Pageof 18